Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 1, 2009, Pages 258-260

  Saverino, Daniele ^a   Riccio, Anna Maria ^b   Rogkakou, Anthi ^b   Bagnasco, Marcello ^a   Bonadonna, Patrizia ^c   Simone, Rita ^a,d   Chiappori, Alessandra ^a   Gamalero, Cinzia ^b   Passalacqua, Giovanni ^b   Canonica, Giorgio Walter ^b   Pesce, Giampaola ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Verona Hospital   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10;

ADOPTIVE IMMUNOTHERAPY; ALLERGY; BLOOD LEVEL; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYMENOPTERA VENOM ALLERGY; IMMUNOMODULATION; LETTER; PRICK TEST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, CD; ARTHROPOD VENOMS; HUMANS; HYMENOPTERA; HYPERSENSITIVITY; IMMUNOTHERAPY; INTERLEUKIN-10; MALE; MIDDLE AGED; T-LYMPHOCYTES, CYTOTOXIC;

EID: 58149117805     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.09.023     Document Type: Letter

References (8)

1. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 36 (2006) 1357-1366
2. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle K., and Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174 (1991) 561-569
3. Thompson B., and Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity 7 (1997) 445-450
4. Oaks M.K., and Hallett K.M. A soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 164 (2000) 5015-5018
5. Saverino D., Brizzolara R., Simone R., Chiappori A., Milintenda Floriani F., Pesce G., et al. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation. Clin Immunol 123 (2007) 190-198
6. Wong C.K., Lun S.W.M., Ko F.W.S., Ip W.K., Hui D.S., and Lam C.V. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol 141 (2005) 122-129
7. Bilò M.B., Rueff F., Mosbech H., Bonifazi F., and Oude-Elberinck A. The EAACI interest group on insect venom hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy 60 (2005) 1339-1349
8. Waterhouse P., Penninger J.M., and Timms E. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270 (1995) 985-988